In hepatocellular carcinoma, hexokinase 2 (HK2), a rate-limiting enzyme in glycolysis, is recognized by the autophagy receptor SQSTM1 and subsequently subjected to selective degradation via the autophagy process. The gene discussed is HK2; the disease is hepatocellular carcinoma.